How to improve care and drive productivity in health providers. What works today? What will work in five years time? Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.
The vast majority of bribes paid by citizens in Europe have to do with access to healthcare, according to an EU anti-corruption report. Healthcare and pharma businesses in Europe are also the most likely of any industry, with 77% agreeing, to think that corruption is widespread in their country. The report puts the total cost of corruption in the EU at €120bn - a little less than the annual EU budget. We look at the underlying numbers.
What are the prospects for investors over the next five years? And what do the numbers tell us about the sector’s recovery? Henrichs looks in-depth at recent valuations, M&A and financing activity. Presented at the Healthcare Europa Annual Conference 2013, New Models for Challenging Times.
Nicolaus has unrivaled access to, and experience
of, European payors. He examines the reform
trajectory and likely budget growth in different
European countries and considers what impact this will have for private hospitals, outsourcers and specialist service providers. Presented at the Healthcare Europa Annual Conference 2013, New Models for Challenging Times.
Synlab, the BC Partners-owned laboratory group, has acquired Laboratoire Dr. Collard in Belgium. Investment banking sources say that the group is still hoping for an IPO in 2014.
Life Sciences Partners, one of the largest European private equity and venture capital investors in biotechnology and pharmaceuticals, is planning to launch a new international fund aimed at medtech and healthcare services....
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
